An in vitro splicing assay reveals the pathogenicity of a novel intronic variant in ATP6V0A4 for autosomal recessive distal renal tubular acidosis

MLA

Tomohiko Yamamura, et al. “An in Vitro Splicing Assay Reveals the Pathogenicity of a Novel Intronic Variant in ATP6V0A4 for Autosomal Recessive Distal Renal Tubular Acidosis.” BMC Nephrology, vol. 18, no. 1, Dec. 2017, pp. 1–5. EBSCOhost, https://doi.org/10.1186/s12882-017-0774-4.

APA

Tomohiko Yamamura, Kandai Nozu, Yuya Miyoshi, Keita Nakanishi, Junya Fujimura, Tomoko Horinouchi, Shogo Minamikawa, Nobuo Mori, Rika Fujimaru, Koichi Nakanishi, Takeshi Ninchoji, Hiroshi Kaito, Taniguchi-Ikeda Mariko, Ichiro Morioka, Masafumi Matsuo, & Kazumoto Iijima. (2017). An in vitro splicing assay reveals the pathogenicity of a novel intronic variant in ATP6V0A4 for autosomal recessive distal renal tubular acidosis. BMC Nephrology, 18(1), 1–5. https://doi.org/10.1186/s12882-017-0774-4

Chicago

Tomohiko Yamamura, Kandai Nozu, Yuya Miyoshi, Keita Nakanishi, Junya Fujimura, Tomoko Horinouchi, Shogo Minamikawa, et al. 2017. “An in Vitro Splicing Assay Reveals the Pathogenicity of a Novel Intronic Variant in ATP6V0A4 for Autosomal Recessive Distal Renal Tubular Acidosis.” BMC Nephrology 18 (1): 1–5. doi:10.1186/s12882-017-0774-4.